Eini elected Histradut chair

December 23, 2005 01:33


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Histadrut Labor Union elected Ofer Eini as its Chairman by an overwhelming majority Thursday, thus replacing Labor Party leader Amir Peretz who served in the position for the last decade. Peretz chose Eini, who for the last year has served in the union's number two position as trade union division director, to complete his term in the position after Peretz was elected to head the Labor Party. Eini will start in his new position January 2 and remain until the beginning of January 2007 when full elections for the position will be held. "The Histadrut will continue to achieve on behalf of workers," Eini said in accepting the position. "We will continue to work to improve social conditions in Israel." Of the 200 Histadrut union members who voted, only nine or 10 went against Eini, said Histadrut spokesman Avinoam Magen.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection